Optical and visual impact of tear break-up in human eyes.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 11095604)

Published in Invest Ophthalmol Vis Sci on December 01, 2000

Authors

R Tutt1, A Bradley, C Begley, L N Thibos

Author Affiliations

1: School of Optometry, Indiana University, Bloomington, Indiana.

Articles citing this

Reliability of a new modified tear breakup time method: dry tear breakup time. Graefes Arch Clin Exp Ophthalmol (2015) 2.35

Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency. Occup Environ Med (2005) 1.31

The challenge of dry eye diagnosis. Clin Ophthalmol (2008) 1.28

Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol (2011) 1.18

Micrometer axial resolution OCT for corneal imaging. Biomed Opt Express (2011) 0.99

Effect of hemodialysis (HD) on intraocular pressure, ocular surface, and macular change in patients with chronic renal failure. Effect of hemodialysis on the ophthalmologic findings. Graefes Arch Clin Exp Ophthalmol (2012) 0.96

Dynamics and function of the tear film in relation to the blink cycle. Prog Retin Eye Res (2014) 0.91

Dry eye, blinking, and blepharospasm. Mov Disord (2002) 0.89

Scale and spatial distribution of aberrations associated with tear breakup. Optom Vis Sci (2012) 0.87

Establishing human lacrimal gland cultures with secretory function. PLoS One (2012) 0.87

Investigation of the isoplanatic patch and wavefront aberration along the pupillary axis compared to the line of sight in the eye. Biomed Opt Express (2012) 0.86

Measurement of the time course of optical quality and visual deterioration during tear break-up. Invest Ophthalmol Vis Sci (2010) 0.85

Dynamic changes in the air-tear film interface modulation transfer function. Graefes Arch Clin Exp Ophthalmol (2009) 0.83

Fluctuations in intraocular pressure and the potential effect on aberrations of the eye. Br J Ophthalmol (2007) 0.82

Spherical aberration and higher order aberrations with Balafilcon A (PureVision) and Comfilcon A (Biofinity). Graefes Arch Clin Exp Ophthalmol (2010) 0.81

Objective and subjective assessing efficacy of a lubricating drop in eyes wearing silicone hydrogel contact lenses. J Curr Ophthalmol (2016) 0.80

Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome. Adv Ther (2015) 0.79

Clinical applications of wavefront refraction. Optom Vis Sci (2014) 0.79

Repeatability and reproducibility of a double-pass optical quality analysis device. PLoS One (2015) 0.79

The impact of higher-order aberrations on the strength of directional signals produced by accommodative microfluctuations. J Vis (2014) 0.79

Forward light scatter analysis of the eye in a spatially-resolved double-pass optical system. Opt Express (2011) 0.78

Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye. Clin Ophthalmol (2011) 0.78

Higher order aberrations of the corneal surface after laser subepithelial keratomileusis. Korean J Ophthalmol (2014) 0.77

Organization of lipids in the tear film: a molecular-level view. PLoS One (2014) 0.77

Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness. BMC Ophthalmol (2015) 0.77

Optical quality of the eye degraded by time-varying wavefront aberrations with tear film dynamics. Jpn J Ophthalmol (2007) 0.76

Fixational eye movements predict visual sensitivity. Proc Biol Sci (2015) 0.76

[Dry eye symptoms following retinal surgery and ocular tumour therapy]. Ophthalmologe (2004) 0.75

Blinking and operating: cognition versus vision. Br J Ophthalmol (2002) 0.75

Evaluation of surface water characteristics of novel daily disposable contact lens materials, using refractive index shifts after wear. Clin Ophthalmol (2015) 0.75

Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal gland. J Control Release (2014) 0.75

The Effects of Increasing Ocular Surface Stimulation on Blinking and Tear Secretion. Invest Ophthalmol Vis Sci (2015) 0.75

Time course of changes in ocular wavefront aberration after administration of eye ointment. Eye (Lond) (2012) 0.75

Ophthalmologic findings in patients with non-surgically treated blowout fractures. Craniomaxillofac Trauma Reconstr (2012) 0.75

A comparison of mesopic visual acuity and objective visual quality following cataract surgery with hydrophobic acrylic intraocular lenses. Clin Ophthalmol (2017) 0.75

[Blinking activity during visual display terminal work. Part 1: Ocular discomfort and pathophysiological principles]. Ophthalmologe (2005) 0.75

Articles by these authors

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell (1991) 14.89

p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature (1999) 13.21

Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49

The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell (1990) 10.99

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature (1995) 8.68

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (1992) 8.16

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (1997) 8.04

Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (1993) 6.75

Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature (1984) 6.54

Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet (1996) 6.06

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (1995) 6.01

A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development (1999) 5.85

Impaired energy homeostasis in C/EBP alpha knockout mice. Science (1995) 5.68

Chromosome engineering in mice. Nature (1995) 5.48

Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91

The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature (1999) 4.74

Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature (1986) 4.73

Requirement for Wnt3 in vertebrate axis formation. Nat Genet (1999) 4.68

Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell (2001) 4.61

Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature (2001) 4.41

In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene (1993) 4.03

Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development (1996) 3.91

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85

BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev (1995) 3.84

Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature (1991) 3.83

A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev (1993) 3.60

Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 3.57

Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature (1992) 3.54

Gene targeting in embryonic stem cells. Methods Enzymol (1993) 3.41

Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet (1995) 3.29

Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet (2000) 3.28

Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol Cell Biol (1991) 3.25

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J (1998) 3.12

Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci U S A (1999) 3.06

Genomic DNA microextraction: a method to screen numerous samples. Anal Biochem (1992) 3.05

Multiple defects and perinatal death in mice deficient in follistatin. Nature (1995) 2.96

The length of homology required for gene targeting in embryonic stem cells. Mol Cell Biol (1991) 2.75

Mouse ENU mutagenesis. Hum Mol Genet (1999) 2.72

Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci U S A (1998) 2.71

Functional analysis of activins during mammalian development. Nature (1995) 2.71

The tumor suppressor p53. Biochim Biophys Acta (1993) 2.65

Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell (1993) 2.62

Different phenotypes for mice deficient in either activins or activin receptor type II. Nature (1995) 2.62

Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature (1999) 2.60

Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J (1993) 2.57

Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell (1993) 2.45

Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol (1996) 2.44

Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev (1995) 2.41

A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature (1987) 2.33

Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet (1998) 2.32

Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol (1993) 2.32

Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci U S A (1995) 2.27

The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell (1992) 2.27

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet (1998) 2.26

Clinical and pharmacological properties of ivermectin in rabbits and guinea pigs. Vet Rec (1992) 2.21

Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene (1994) 2.20

Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog (1995) 2.18

The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev (1995) 2.07

Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci U S A (1998) 2.00

Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev (1994) 1.99

Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J (2000) 1.91

Altered segmental identity and abnormal migration of motor neurons in mice lacking Hoxb-1. Nature (1997) 1.89

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A (1994) 1.88

Engineering chromosomal rearrangements in mice. Nat Rev Genet (2001) 1.85

The role and fate of DNA ends for homologous recombination in embryonic stem cells. Mol Cell Biol (1992) 1.71

Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications. Mol Cell Biol (2000) 1.71

A randomized, controlled trial of routine early abdominal computed tomography in patients presenting with non-specific acute abdominal pain. Clin Radiol (2007) 1.70

Engineering a mouse balancer chromosome. Nat Genet (1999) 1.68

The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2. Proc Natl Acad Sci U S A (1996) 1.62

Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J Immunol (1999) 1.61

A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res (1999) 1.61

A clone-array pooled shotgun strategy for sequencing large genomes. Genome Res (2001) 1.60

Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A (1994) 1.60

High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature (1995) 1.57

Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev Biol (1999) 1.55

The effects of contrast on visual orientation and spatial frequency discrimination: a comparison of single cells and behavior. J Neurophysiol (1987) 1.51

A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat Genet (1995) 1.49

Visual orientation and spatial frequency discrimination: a comparison of single neurons and behavior. J Neurophysiol (1987) 1.49

A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells. Genesis (2000) 1.49

An anchored framework BAC map of mouse chromosome 11 assembled using multiplex oligonucleotide hybridization. Genomics (1998) 1.46

The chromatic eye: a new reduced-eye model of ocular chromatic aberration in humans. Appl Opt (1992) 1.41

Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. Genetics (1998) 1.41

Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res (1995) 1.40

The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol (2005) 1.40

Disruption of an imprinted gene cluster by a targeted chromosomal translocation in mice. Nat Genet (2001) 1.38

The response properties of the steady antagonistic surround in the mudpuppy retina. J Physiol (1978) 1.35

Recycling selectable markers in mouse embryonic stem cells. Mol Cell Biol (1996) 1.34

Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed. Genes Dev (1995) 1.34

Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience (2002) 1.33

Analysis of orientation bias in cat retina. J Physiol (1982) 1.32

How reliable are commercial allergy tests? Lancet (1987) 1.32

Outcomes of hand surgery. British Society for Surgery of the Hand. J Hand Surg Br (1995) 1.31

Targeting frequency for deletion vectors in embryonic stem cells. Mol Cell Biol (1994) 1.29

From mouse to man: generating megabase chromosome rearrangements. Trends Genet (2001) 1.25

Retinal limits to the detection and resolution of gratings. J Opt Soc Am A (1987) 1.24

A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum Mol Genet (1993) 1.22

Theory and measurement of ocular chromatic aberration. Vision Res (1990) 1.22